Johnson & Johnson (
) will begin trading ex-dividend on August 23, 2013. A cash
dividend payment of $0.66 per share is scheduled to be paid on
September 10, 2013. Shareholders who purchased JNJ stock prior to
the ex-dividend date are eligible for the cash dividend payment.
This represents an 8.2% increase over the same period a year ago.
At the current stock price of $88.8, the dividend yield is
The previous trading day's last sale of JNJ was $88.8,
representing a -5.95% decrease from the 52 week high of $94.42 and
a 32.83% increase over the 52 week low of $66.85.
JNJ is a part of the Health Care sector, which includes
companies such as Pfizer, Inc. (
) and Novartis AG (
). JNJ's current earnings per share, an indicator of a company's
profitability, is $4.51. Zacks Investment Research reports JNJ's
forecasted earnings growth in 2013 as 7.32%, compared to an
industry average of -3.7%.
For more information on the declaration, record and payment
dates, visit the
Interested in gaining exposure to JNJ through an Exchange
Traded Fund [ETF]?
The following ETF(s) have JNJ as a top-10 holding:
- Select Sector SPDR Fund - Health Care (
- iShares Dow Jones U.S. Health Care Index Fund (
- Merrill Lynch Pharmaceutical HOLDRS (
- Vanguard Health Care ETF (
- iShares U.S. Pharmaceutical ETF (
The top-performing ETF of this group is IHE with an increase of
9.27% over the last 100 days. XLV has the highest percent weighting
of JNJ at 13.3%.